Literature DB >> 11880440

Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain.

James A Karlowsky1, Ian A Critchley, Renée S Blosser-Middleton, Elena A Karginova, Mark E Jones, Clyde Thornsberry, Daniel F Sahm.   

Abstract

A 2000-2001 U.S. Haemophilus influenzae surveillance study (n = 1,434) detected nine (0.6%) beta-lactamase-negative and ampicillin-resistant (BLNAR) isolates collected from two different hospitals. The MICs of ampicillin for all nine isolates were 4 microg/ml, with results being reproducible; and all nine isolates were susceptible to amoxicillin-clavulanate, cefuroxime, cefprozil, macrolides, and fluoroquinolones. Pulsed-field gel electrophoresis of genomic DNA following SmaI digestion demonstrated identical patterns for each of the nine isolates, suggesting intra- and interhospital dissemination of a BLNAR clone.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11880440      PMCID： PMC120287          DOI： 10.1128/JCM.40.3.1063-1066.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Ampicillin-resistant Haemophilus influenzae type B infection.

Authors:  M O Tomeh; S E Starr; J E McGowan; P M Terry; A J Nahmias
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

2.  A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States.

Authors:  R N Jones; M R Jacobs; J A Washington; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1997-03       Impact factor: 2.803

3.  Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.

Authors:  G V Doern; A B Brueggemann; G Pierce; H P Holley; A Rauch
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

Review 4.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999.

Authors:  F Marco; J García-de-Lomas; C García-Rey; E Bouza; L Aguilar; C Fernández-Mazarrasa
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

6.  A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates.

Authors:  S F Rittenhouse; L A Miller; R L Kaplan; G H Mosely; J A Poupard
Journal:  Diagn Microbiol Infect Dis       Date:  1995-04       Impact factor: 2.803

7.  Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group.

Authors:  G V Doern
Journal:  J Antimicrob Chemother       Date:  1996-07       Impact factor: 5.790

8.  Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.

Authors:  G V Doern; J H Jorgensen; C Thornsberry; D A Preston
Journal:  Diagn Microbiol Infect Dis       Date:  1986-02       Impact factor: 2.803

9.  Epidemiology of rob beta-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United States.

Authors:  R S Daum; M Murphey-Corb; E Shapira; S Dipp
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

10.  National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.

Authors:  G V Doern; J H Jorgensen; C Thornsberry; D A Preston; T Tubert; J S Redding; L A Maher
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191
View more
  19 in total

1.  Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin.

Authors:  Frank S Kaczmarek; Thomas D Gootz; Fadia Dib-Hajj; Wenchi Shang; Shawn Hallowell; Melissa Cronan
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.

Authors:  In-Suk Kim; Chang-Seok Ki; Sunjoo Kim; Won Sup Oh; Kyong Ran Peck; Jae-Hoon Song; Kyungwon Lee; Nam Yong Lee
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Short report: antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including beta-lactamase-negative ampicillin-resistant strains.

Authors:  L Qin; H Watanabe; N Asoh; K Watanabe; K Oishi; T Mizota; T Nagatake
Journal:  Epidemiol Infect       Date:  2006-09-06       Impact factor: 2.451

4.  Epidemiology and evolution of antibiotic resistance of Haemophilus influenzae in children 5 years of age or less in France, 2001-2008: a retrospective database analysis.

Authors:  H Dabernat; C Delmas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-27       Impact factor: 3.267

5.  Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.

Authors:  Tatiana Bogdanovich; Catherine Clark; Lois Ednie; Gengrong Lin; Kathy Smith; Stuart Shapiro; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

6.  Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.

Authors:  Sho Takahata; Yoshihisa Kato; Yumiko Sanbongi; Kazunori Maebashi; Takashi Ida
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

7.  Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins.

Authors:  Atsushi Uda; Takeshi Kimura; Sho Nishimura; Kei Ebisawa; Goh Ohji; Mari Kusuki; Mariko Yahata; Rie Izuta; Tomoyuki Sakaue; Tatsuya Nakamura; Chihiro Koike; Issei Tokimatsu; Ikuko Yano; Kentaro Iwata; Takayuki Miyara
Journal:  Infection       Date:  2019-10-11       Impact factor: 3.553

8.  Increase of β-lactam-resistant invasive Haemophilus influenzae in Sweden, 1997 to 2010.

Authors:  Fredrik Resman; Mikael Ristovski; Arne Forsgren; Bertil Kaijser; Göran Kronvall; Patrik Medstrand; Eva Melander; Inga Odenholt; Kristian Riesbeck
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

9.  Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.

Authors:  Silvia García-Cobos; José Campos; Edurne Lázaro; Federico Román; Emilia Cercenado; César García-Rey; María Pérez-Vázquez; Jesús Oteo; Francisco de Abajo
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

10.  Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.

Authors:  Songmee Bae; Jaehoon Lee; Jaehwa Lee; Eunah Kim; Sunhwa Lee; Jaeyon Yu; Yeonho Kang
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.